Fundraising Fox

3Bar Biologics

Columbus, US · Founded 2013 · Ohio corporation · 2 known investors

Find your way into 3Bar Biologics

Founders & leadership

BCBruce Caldwell
Bruce CaldwellinCEO

Board

DBDavid Bergeron
David BergeronBoard directorAdvisory Partner, Advanced Technologies at Rev1 Ventures
RM
Richard MaksimoskiBoard director
RA
Rashmi AgnihotriBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$2.4M disclosed across 2 rounds · 2016–2020

$780KraisedNov 2020 · 11 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard MaksimoskiDirector
  • Bruce CaldwellExecutive Officer, Director
  • David BergeronDirector
  • Rashmi AgnihotriDirector
Offering amount
$1M
Amount sold
$780K
First sale
Nov 2020
Incorporated
Corporation, Ohio
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.6MraisedApr 2017 · 12 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David BergeronDirector
  • Bruce CaldwellExecutive Officer, Director
  • Richard MaksimoskiDirector
  • Rashmi AgnihotriDirector
Offering amount
$2M
Amount sold
$1.6M
Minimum investment
$10K
First sale
Dec 2016
Incorporated
Corporation, Ohio, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap
Third Arc Bio10 shared keywordsThird Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering. The company is led by a team with a track record of 35+ drug approvals.
3T Biosciences10 shared keywords3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets. The company creates therapeutic treatments targeting cancer and other difficult-to-treat diseases.
TripleBar Bio, Inc.7 shared keywordsTriplebar builds an AI platform for Genomic Design Automation (GDA), using microfluidics to generate large-scale biological datasets with matched genotype and phenotype at lower cost and faster than liquid handling robotics. It applies machine learning to biological data to support biotechnology research and product engineering.
3PBIOVIAN5 shared keywords3PBIOVIAN is a global Contract Development and Manufacturing Organization (CDMO) providing end-to-end biopharmaceutical manufacturing services for biotech and pharma companies. The company offers microbial and mammalian protein expression, viral vector production, cell therapy, plasmid DNA production, and fill & finish services across multiple locations in Spain, Finland, and the United States.
32 Biosciences Website5 shared keywordsA biotech company focused on microbiome and metabolomics research for gastrointestinal health applications, with leadership and scientific advisory rooted in academic medicine and regulatory expertise.

Companies competing with 3Bar Biologics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 4 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
Department of Agriculture (USDA)Phase II2022$650K
Department of Agriculture (USDA)Phase I2021$100K
Department of Agriculture (USDA)Phase II2017$600K
Department of Agriculture (USDA)Phase I2016$100K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

Who are 3Bar Biologics's investors?
3Bar Biologics's investors include Rev1 Ventures, S2G Investments.
How much funding has 3Bar Biologics raised?
3Bar Biologics has disclosed $2.4M raised across 2 rounds.
Where is 3Bar Biologics headquartered?
3Bar Biologics is headquartered in Columbus, US.